Insider Trading Alert - CFN, RMAX And LABL Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Dec. 5, 2014, 98 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $85.00 to $13,664,800.00.

Highlighted Stocks Traded by Insiders:

CareFusion (CFN) - FREE Research Report

Abbey Donald, who is EVP, Quality Reg & Med Affairs at CareFusion, sold 1,000 shares at $59.35 on Dec. 5, 2014. Following this transaction, the EVP, Quality Reg & Med Affairs owned 31,959 shares meaning that the stake was reduced by 3.03% with the 1,000-share transaction.

The shares most recently traded at $59.21, down $0.14, or 0.24% since the insider transaction. Historical insider transactions for CareFusion go as follows:

  • 4-Week # shares sold: 11,000
  • 12-Week # shares sold: 11,000
  • 24-Week # shares sold: 20,605

The average volume for CareFusion has been 3.4 million shares per day over the past 30 days. CareFusion has a market cap of $12.1 billion and is part of the health care sector and health services industry. Shares are up 48.39% year-to-date as of the close of trading on Friday.

CareFusion Corporation, a medical technology company, provides various healthcare products and services. It offers product lines in the areas of medication management, infection prevention, operating room effectiveness, and respiratory care. The company has a P/E ratio of 30.1. Currently, there are no analysts who rate CareFusion a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CFN - FREE

TheStreet Quant Ratings rates CareFusion as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, reasonable valuation levels and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full CareFusion Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

RE/MAX Holdings (RMAX) - FREE Research Report

Predovich Daniel J., who is Director at RE/MAX Holdings, sold 1,410 shares at $35.45 on Dec. 5, 2014. Following this transaction, the Director owned 883 shares meaning that the stake was reduced by 61.49% with the 1,410-share transaction.

The shares most recently traded at $36.56, up $1.11, or 3.04% since the insider transaction.

The average volume for RE/MAX Holdings has been 64,600 shares per day over the past 30 days. RE/MAX Holdings has a market cap of $405.4 million and is part of the financial sector and real estate industry. Shares are up 15.93% year-to-date as of the close of trading on Friday.

RE/MAX Holdings, Inc. operates as a franchisor for residential and commercial real estate brokerage services in the United States and internationally. It operates in two segments, Real Estate Franchise Services, and Brokerage and Other. The stock currently has a dividend yield of 0.72%. The company has a P/E ratio of 34.2. Currently, there are 3 analysts who rate RE/MAX Holdings a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RMAX - FREE

TheStreet Quant Ratings rates RE/MAX Holdings as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we find that net income has been generally deteriorating over time. Get the full RE/MAX Holdings Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Multi-Color (LABL) - FREE Research Report

Mohr Thomas M, who is Director at Multi-Color, sold 3,650 shares at $55.01 on Dec. 5, 2014. Following this transaction, the Director owned 14,165 shares meaning that the stake was reduced by 20.49% with the 3,650-share transaction.

The shares most recently traded at $54.26, down $0.75, or 1.38% since the insider transaction. Historical insider transactions for Multi-Color go as follows:

  • 12-Week # shares bought: 14,400
  • 24-Week # shares bought: 14,400

The average volume for Multi-Color has been 68,800 shares per day over the past 30 days. Multi-Color has a market cap of $911.4 million and is part of the services sector and diversified services industry. Shares are up 45.89% year-to-date as of the close of trading on Friday.

Multi-Color Corporation provides various label solutions. The stock currently has a dividend yield of 0.36%. The company has a P/E ratio of 25.1. Currently, there are 2 analysts who rate Multi-Color a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LABL - FREE

TheStreet Quant Ratings rates Multi-Color as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, reasonable valuation levels, good cash flow from operations and compelling growth in net income. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Multi-Color Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

FTC Chair Says Agency Is Ready to Take on Big Tech; Walgreens Joins Dow -- ICYMI

FTC Chair Says Agency Is Ready to Take on Big Tech; Walgreens Joins Dow -- ICYMI

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists